891 results on '"Radstake, Timothy R D J"'
Search Results
2. RegEnrich gene regulator enrichment analysis reveals a key role of the ETS transcription factor family in interferon signaling
3. Unraveling IFN-I response dynamics and TNF crosstalk in the pathophysiology of systemic lupus erythematosus
4. Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist’s, Clinician’s, and Patient’s Perspective
5. New insights into the genetics and epigenetics of systemic sclerosis
6. Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis
7. Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients
8. Morphea and Eosinophilic Fasciitis: An Update
9. Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c + Dendritic Cell Dysregulation in Systemic Sclerosis
10. Machine learning in rheumatology approaches the clinic
11. Control of cytokine mRNA degradation by the histone deacetylase inhibitor ITF2357 in rheumatoid arthritis fibroblast-like synoviocytes: beyond transcriptional regulation
12. Differential isoform expression of Allergin‐1 during acute and chronic inflammation
13. HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients
14. The Effect of Body Fat Distribution on Systemic Sclerosis
15. Systemic and local granzyme B levels are associated with disease activity, kidney damage and interferon signature in systemic lupus erythematosus
16. Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögrenʼs Syndrome: Potential New Axis in Lymphoid Neogenesis
17. Association of MicroRNA‐618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis
18. Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response.
19. HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients.
20. Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment
21. A Network of Serum Proteins Predict the Need for Systemic Immunomodulatory Therapy at Diagnosis in Noninfectious Uveitis
22. CXCL4 drives fibrosis by promoting several key cellular and molecular processes
23. ZFP36 family members regulate the pro-inflammatory features of psoriatic dermal fibroblasts
24. The effect of body fat distribution on systemic sclerosis.
25. The effect of body fat distribution on systemic sclerosis.
26. Central Role of Semaphorin 3B in a Serum‐Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis
27. Activation-induced colocalisation of SCAMP5 with IFNα in human plasmacytoid dendritic cells
28. Impaired Porphyromonas gingivalis–Induced Tumor Necrosis Factor Production by Dendritic Cells Typifies Patients With Rheumatoid Arthritis
29. Transcriptome network analysis implicates CX3CR1-positive type 3 dendritic cells in non-infectious uveitis.
30. Deciphering the role of cDC2s in Sjögren's syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity.
31. Gout Is a Chronic Inflammatory Disease in Which High Levels of Interleukin-8 (CXCL8), Myeloid-Related Protein 8/Myeloid-Related Protein 14 Complex, and an Altered Proteome Are Associated With Diabetes Mellitus and Cardiovascular Disease
32. Thymic stromal lymphopoietin as a novel mediator amplifying immunopathology in rheumatic disease
33. Perception of self: distinguishing autoimmunity from autoinflammation
34. Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis.
35. Signaling by the inhibitory receptor CD200R is rewired by type I interferon
36. Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α
37. Genetics of Systemic Sclerosis: An Update
38. Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus
39. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis
40. Immune responses to stress in rheumatoid arthritis and psoriasis
41. Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin
42. Does stress affect the joints? Daily stressors, stress vulnerability, immune and HPA axis activity, and short-term disease and symptom fluctuations in rheumatoid arthritis
43. Thymic Stromal Lymphopoietin, a Novel Proinflammatory Mediator in Rheumatoid Arthritis That Potently Activates CD1c+ Myeloid Dendritic Cells to Attract and Stimulate T Cells
44. Targeting Th2-typified immune responses to prevent immunopathology in rheumatic diseases: belittled therapeutic strategies?
45. The Transcriptomic Profile of Monocytes from Patients With Sjögren’s Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators
46. Transcriptome Analysis of CCR9+ T Helper Cells From Primary Sjögren’s Syndrome Patients Identifies CCL5 as a Novel Effector Molecule
47. Reply
48. Genomic Risk Score impact on susceptibility to systemic sclerosis
49. Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes
50. Signaling by the inhibitory receptor CD200R is rewired by type I interferon
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.